XL-protein and Antlia Bioscience announce collaboration to develop long-acting peptide therapy of chronic heart failure using PASylation® Technology
October 15, 2020
October 15, 2020
July 7, 2020
March 23, 2020
February 26, 2020
February 11, 2020
February 7, 2020
February 6, 2020
February 3, 2020
February 3, 2020
December 16, 2024
BetaGlue® Therapeutics S.p.A. (“BetaGlue”) an Italian clinical-stage oncology company developing an innovative radiotherapy platform for the targeted ...
December 11, 2024
The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to...
December 10, 2024
Innovative Cell Expansion System Enables Real-Time Metabolic Monitoring and Automated Culture Optimization to Accelerate Cell and Gene Therapy Manufac...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225